logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Jakobsen, Bent Karsten
    Born in August 1959
    Individual (5 offsprings)
    Officer
    2020-12-15 ~ now
    OF - Director → CIF 0
  • 2
    Zou, Ling
    Born in June 1988
    Individual (1 offspring)
    Officer
    2021-06-16 ~ now
    OF - Director → CIF 0
  • 3
    Laing, Ian Michael
    Born in December 1946
    Individual (14 offsprings)
    Officer
    2025-10-23 ~ now
    OF - Director → CIF 0
  • 4
    Cross, Nicholas John
    Born in March 1947
    Individual (12 offsprings)
    Officer
    2020-12-15 ~ now
    OF - Director → CIF 0
Ceased 2
  • 1
    Bent Karsten Jakobsen
    Born in August 1959
    Individual (5 offsprings)
    Person with significant control
    2020-12-15 ~ 2022-05-04
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Robinson, Hans Ivar
    Born in May 1967
    Individual
    Officer
    2021-08-17 ~ 2025-10-22
    OF - Director → CIF 0
parent relation
Company in focus

ACCESSION THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology

Related profiles found in government register
  • ACCESSION THERAPEUTICS LIMITED
    Info
    Registered number 13083685
    Building 7600c The Quorum, Alec Issigonis Way, Arc Oxford North, Oxford OX4 2JZ
    PRIVATE LIMITED COMPANY incorporated on 2020-12-15 (5 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-12-14
    CIF 0
  • ACCESSION THERAPEUTICS LIMITED
    S
    Registered number 13083685
    Building 7600c The Quorum, Alec Issigonis Way, Arc Oxford North, Oxford, England, OX4 2JZ
    Limited By Shares in Companies House, United Kingdom
    CIF 1
  • ACCESSION THERAPEUTICS LIMITED
    S
    Registered number 13083685
    Building 7600c The Quorum, Alec Issigonis Way, Arc Oxford North, Oxford, United Kingdom, OX4 2JZ
    Limited By Shares in Companies House, United Kingdom
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    ACCESSION TX LIMITED - 2020-12-18
    ACCESSION THERAPEUTICS LIMITED - 2020-12-07
    Building 7600c The Quorum, Alec Issigonis Way, Arc Oxford North, Oxford, United Kingdom
    Active Corporate (3 parents)
    Equity (Company account)
    100 GBP2024-12-31
    Person with significant control
    2020-12-16 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Right to appoint or remove directorsOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
  • 2
    Building 7600c The Quorum, Alec Issigonis Way, Arc Oxford North, Oxford, United Kingdom
    Active Corporate (3 parents)
    Equity (Company account)
    1 GBP2024-12-31
    Person with significant control
    2021-09-07 ~ now
    CIF 2 - Ownership of voting rights - 75% or moreOE
    CIF 2 - Right to appoint or remove directorsOE
    CIF 2 - Ownership of shares – 75% or moreOE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.